Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1129-2377
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials ; volume:22 ; number:1 ; day:7 ; month:1 ; year:2021 ; pages:1-11 ; date:12.2021
The journal of headache and pain ; 22, Heft 1 (7.1.2021), 1-11, 12.2021
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Silberstein, Stephen D.
Cohen, Joshua M.
Yang, Ronghua
Gandhi, Sanjay K.
Du, Evelyn
Jann, Adelene E.
Marmura, Michael J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10194-020-01212-4
- URN
-
urn:nbn:de:101:1-2021020802350519599993
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silberstein, Stephen D.
- Cohen, Joshua M.
- Yang, Ronghua
- Gandhi, Sanjay K.
- Du, Evelyn
- Jann, Adelene E.
- Marmura, Michael J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis
Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder
The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials
Manager Peel taking his farewell benefit
Artificial First Responder
Hypoxische pulmonale Vasokonstriktion bei experimenteller Hypoxie : Responder und Non-Responder
¡Cómo iba a responder!
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
A olvido hay que responder
Responder identification in clinical trials
Protein dynamics in responder and non-responder solid tumor xenografts during oncolytic viral therapy
Autologous chondrocyte implantation-derived synovial fluids display distinct responder and non-responder proteomic profiles
Alvimopan for the Management of Postoperative Ileus After Bowel Resection: Characterization of Clinical Benefit by Pooled Responder Analysis